Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

NCT05622812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2025-03-07

Study results available
· View outcomes & findings →

Summary

This study is designed to evaluate effectiveness and safety of Restylane Lyft Lidocaine for Jawline definition

Conditions

  • Jawline Definition

Interventions

DEVICE

Restylane Lyft Lidocaine

Treatment for Jawline definition

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Study Director · Galderma R&D

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-16
Primary Completion
2023-10-16
Completion
2024-06-14

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05622812 on ClinicalTrials.gov